ARCHIVES

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

This article is from The Cancer Letter archive.

Vol. 27 No. 3 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs

December 4, 1992

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

CREG Announcement June 1 Includes 17 Projects Worth $4.1 Million

May 16, 1975

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010